Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jun 2;25(11):2594.
doi: 10.3390/molecules25112594.

Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers

Anne-Lise Bienvenu  1   2   3 , Stephane Picot  3   4
Affiliations
Review

Mycetoma and Chromoblastomycosis: Perspective for Diagnosis Improvement Using Biomarkers

Anne-Lise Bienvenu et al. Molecules. .

Abstract

Background: Mycetoma and chromoblastomycosis are both chronic subcutaneous infectious diseases that pose an obstacle to socioeconomic development. Besides the therapeutic issue, the diagnosis of most neglected tropical diseases (NTD) is challenging. Confirmation using direct microscopy and culture, recognized as WHO essential diagnostic tests, are limited to specialized facilities. In this context, there is a need for simple user-friendly diagnostic tests to be used in endemic villages.

Methods: This review discuss the available biomarkers that could help to improve the diagnostic capacity for mycetoma and chromoblastomycosis in a theoretical and practical perspective.

Results: A lack of research in this area has to be deplored, mainly for mycetoma. Biomarkers based on the immune response (pattern of leucocytes, antibody detection), the dermal involvement (extracellular matrix monitoring, protein expression), and the presence of the infectious agent (protein detection) are potential candidates for the detection or follow-up of infection.

Conclusion: Confirmatory diagnosis based on specific diagnostic biomarkers will be the basis for the optimal treatment of mycetoma and chromoblastomycosis. It will be part of the global management of NTDs under the umbrella of stewardship activities.

Keywords: biomarkers; chromoblastomycosis; diagnosis; mycetoma; neglected tropical disease.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. van de Sande W.W.J. Global burden of human mycetoma: A systematic review and meta-analysis. PLoS Negl. Trop. Dis. 2013;7:e2550. doi: 10.1371/journal.pntd.0002550. - DOI - PMC - PubMed
    1. Queiroz-Telles F., Fahal A.H., Falci D.R., Caceres D.H., Chiller T., Pasqualotto A.C. Neglected endemic mycoses. Lancet Infect. Dis. 2017;17:e367–e377. doi: 10.1016/S1473-3099(17)30306-7. - DOI - PubMed
    1. Fahal A.H. Mycetoma: A global medical and socio-economic dilemma. PLoS Negl. Trop. Dis. 2017;11:e0005509. doi: 10.1371/journal.pntd.0005509. - DOI - PMC - PubMed
    1. Hay R., Denning D.W., Bonifaz A., Queiroz-Telles F., Beer K., Bustamante B., Chakrabarti A., Chavez-Lopez M.d.G., Chiller T., Cornet M., et al. The Diagnosis of Fungal Neglected Tropical Diseases (Fungal NTDs) and the Role of Investigation and Laboratory Tests: An Expert Consensus Report. Trop. Med. Infect. Dis. 2019;4 doi: 10.3390/tropicalmed4040122. - DOI - PMC - PubMed
    1. Schneider G.X., Gomes R.R., Bombassaro A., Zamarchi K., Voidaleski M.F., Costa F.F., Leão A.C.R., Lima B.J.F.S., Soley B.S., Colombo I.R., et al. New Molecular Markers Distinguishing Fonsecaea Agents of Chromoblastomycosis. Mycopathologia. 2019;184:493–504. doi: 10.1007/s11046-019-00359-2. - DOI - PubMed

LinkOut - more resources